Skip to main content
SpringerLink
Log in

Early stage medically inoperable non-small cell lung cancer

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

A nihilistic approach to the treatment of patients with medically inoperable, early stage non-small cell lung cancer (NSCLC) is not warranted. Despite the frequency of comorbid medical illness in patients with medically inoperable NSCLC, lung cancer progression is the major cause of morbidity and death. Although expectations for cure are reduced compared to good-risk patients (eg, adequate pulmonary reserve), modest long-term survival rates of patients have been reported, after definitive therapy. A comparison of radiotherapy and limited resection is difficult because of the lack of randomized data and the selection bias inherent in retrospective reports. For example, patients treated with surgery have peripheral lesions, undergoing rigorous staging compared to patients treated with radiotherapy. In a multidisciplinary thoracic program, patients are counseled on the options of sublobar resection and conformal radiotherapy. The efficacy of adjuvant radiotherapy, after limited resection, in reducing local recurrence in patients with medically inoperable NSCLC is unclear. However, adjuvant radiotherapy may be considered if a postoperative target volume can be defined, particularly if resection margins are narrow. Considering the benefit of chemoradiotherapy for patients with locally advanced disease, combination therapy is administered to patients with good performance status and large (eg, > 4 cm) primary lesions, although combined therapy may increase the potential for pulmonary toxicity in patients with baseline pulmonary dysfunction. Prospective data are becoming available to define the value of treatment alternatives for patients with medically inoperable NSCLC. The Cancer and Leukemia Group B completed a phase II study of thoracoscopic wedge resection and postoperative radiotherapy, whereas a phase I trial of dose-intensive accelerated conformal radiotherapy is ongoing. Trials involving systemic therapy for patients with medically inoperable NSCLC should be developed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Cancer Facts and Figures 2002. Atlanta, GA: American Cancer Society; 2002.

  2. Mettlin CJ, Menck HR, Murphy GP, et al.: A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology and End Results Program? Cancer 1997, 79:2052–2061.

    Article  PubMed  CAS  Google Scholar 

  3. Williams DE, Pairolero PC, Davis CS, et al.: Survival of patients surgically treated for stage I lung cancer? J Thorac Cardiovasc Surg 1981, 82:70–76.

    PubMed  CAS  Google Scholar 

  4. Yancik R: Cancer burden in the aged? Cancer 1997, 80:1273–1283.

    Article  PubMed  CAS  Google Scholar 

  5. Henschke CI, McCauley DI, Uankelevitz DF, et al.: Early lung cancer action project: overall design and findings from baseline screening? Lancet 1999, 354:99–105. Detailed findings of a prospective trial evaluating low-dose spiral CT scan screening for patients at high risk for NSCLC.

    Article  PubMed  CAS  Google Scholar 

  6. Gauden S, Ramsay J, Tripcony L: The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung? Chest 1995, 108:1278–1282. The largest single-institution analysis of radiotherapy for early stage NSCLC.

    PubMed  CAS  Google Scholar 

  7. Miller JI, Hatcher CR: Limited resection of bronchogenic carcinoma in the patient with marked impairment of pulmonary function? Ann Thorac Surg 1987, 44:340–343.

    Article  PubMed  CAS  Google Scholar 

  8. Pastorino U, Valente M, Bedini V, et al.: Results of conservative surgery for stage I lung cancer? Tumori 1990, 76:38–43.

    PubMed  CAS  Google Scholar 

  9. Ginsberg RJ, Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group? Ann Thorac Surg 1995, 60:622–623. Prospective trial detailing the superiority of lobectomy for stage I NSCLC in fit patients.

    Article  Google Scholar 

  10. Weisman IM: Cardiopulmonary exercise testing in the preoperative assessment for lung resection surgery? Semin Thorac Cardiovasc Surg 2001, 13:116–125.

    Article  PubMed  CAS  Google Scholar 

  11. Errett LE, Wilson J, Chiu RC, et al.: Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients? J Thorac Cardiovasc Surg 1985, 90:656–661.

    PubMed  CAS  Google Scholar 

  12. Mentzer SJ, DeCamp MM, Harpole DH Jr, et al.: Thoracoscopy and video-assisted thoracic surgery in the treatment of lung cancer? Chest 1995, 107:298S-301S.

    PubMed  CAS  Google Scholar 

  13. Shennib H, Bogart JA, Herndon J, et al.: Thorascopic wedge resection and radiotherapy for T1N0 non-small cell lung cancer (NSCLC) in high risk patients: preliminary analysis of a Cancer and Leukemia Group B and Eastern Cooperative Oncology Group phase II trial [abstract]? Int J Radiat Oncol Biol Phys 2000, 48:232. Initial report of the first prospective cooperative group trial evaluating therapy for patients with stage I NSCLC and cardiopulmonary dysfunction.

    Article  Google Scholar 

  14. Dieter RJ, Kuzycz GB: Complications and contraindications of thoracoscopy? Int Surg 1997, 82:232–239.

    PubMed  Google Scholar 

  15. Parekh K, Rusch V, Baines M, et al.: VATS port site recurrence: a technique dependent problem? Ann Surg Oncol 2001, 8:175–178.

    Article  PubMed  CAS  Google Scholar 

  16. Bogart J, Shennib H, Kohman L, et al.: Postoperative radiotherapy following thorascopic wedge resection of T1 non-small cell lung cancer in high risk patients: a Cancer and Acute Leukemia Group B and Eastern Cooperative Oncology Group phase II trial [abstract]? Proc Am Soc Clin Oncol 2000, 19:488a.

    Google Scholar 

  17. Postoperative radiotherapy in non-small-cell lung cancer: systemic review and meta-analysis of individual patient data from nine randomized controlled trials. PORT Meta-analysis Trialists Group.Lancet 1998, 352:257–263. Overview suggesting a detriment for the use of postoperative radiotherapy in patients with early stage NSCLC.

  18. Trodella L, Granone P, Valente S, et al.: Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial? Radiother Oncol 2002, 62:11–19. Prospective randomized trial showing a survival benefit for patients receiving postoperative radiotherapy for stage I NSCLC.

    Article  PubMed  Google Scholar 

  19. Chen A, Galloway M, Landreneau R, et al.: Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma? Int J Radiat Oncol Biol Phys 1999, 44:1057–1063.

    Article  PubMed  CAS  Google Scholar 

  20. Rowell NP, Williams CJ: Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review? Thorax 2001, 56:628–638. Comprehensive review of radiotherapy in the treatment of patients with medically inoperable NSCLC.

    Article  PubMed  CAS  Google Scholar 

  21. Sibley GS: Radiotherapy for patients with medically inoperable stage I non-small cell lung carcinoma? Cancer 1998, 82:433–438.

    Article  PubMed  CAS  Google Scholar 

  22. Krol A, Aussems P, Noordijk EM, et al.: Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 1996, 34:297–302.

    Article  PubMed  CAS  Google Scholar 

  23. Graham PH, Gebski VJ, Langlands AO: Radical radiotherapy for early stage non-small cell lung cancer? Int J Radiat Oncol Biol Phys 1995, 31:261–266.

    Article  PubMed  CAS  Google Scholar 

  24. Dosoretz DE, Katin MJ, Blitzer PH, et al.: Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies? Int J Radiat Oncol Biol Phys 1992, 24:3–9.

    PubMed  CAS  Google Scholar 

  25. Morita K, Kuwa N, Suzuki Y, et al.: Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients? Radiother Oncol 1997, 42:31–36.

    Article  PubMed  CAS  Google Scholar 

  26. Abratt RP: Modeling tumor and treated lung volume influences in the irradiation of non-small cell lung cancer patients? Int J Radiat Oncol Biol Phys 2001, 49:481–485.

    Article  PubMed  CAS  Google Scholar 

  27. Graham MV, Winter K, Purdy JA, et al.: Preliminary results of a Radiation Therapy Oncology Group trial (RTOG 9311), a dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer [abstract]? Int J Radiat Oncol Biol Phys 2001, 51:19–20.

    Article  Google Scholar 

  28. Hayman JA, Martel MK, Ten Haken RK, et al.: Dose escalation in non-small-cell lung cancer using threedimensional conformal radiation therapy: update of a phase I trial? J Clin Oncol 2001, 19:127–136.

    PubMed  CAS  Google Scholar 

  29. Bradley JD, Ieumwananonthachai N, Purdy JA, et al.: Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma? Int J Radiat Oncol Biol Phys 2002, 52:49–57.

    Article  PubMed  Google Scholar 

  30. Willner J, Caragiani E, Tschammler A, et al.: The influence of total dose and tumor volume on local control and survival in non-small cell lung cancer [abstract]? Int J Radiat Oncol Biol Phys 2000, 48:327.

    Article  Google Scholar 

  31. Mehta M, Scrimger R, Mackie R, et al.: A new approach to dose escalation in non-small-cell lung cancer? Int J Radiat Oncol Biol Phys 2001, 49:23–33. Details the rationale for radiation dose escalation without extending the time to complete treatment.

    Article  PubMed  CAS  Google Scholar 

  32. Sugi K, Nawata K, Fujita N, et al.: Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter? World J Surg 1998, 22:290–294.

    Article  PubMed  CAS  Google Scholar 

  33. Rosenzweig KE, Sim SE, Mychalczak B, et al.: Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy? Int J Radiat Oncol Biol Phys 2001, 50:681–685.

    Article  PubMed  CAS  Google Scholar 

  34. Langenduk JA, Aaronson NK, De Jong JMA, et al.: Quality of life after curative radiotherapy in stage I non-small-cell lung carcinoma? Int J Radiat Oncol Biol Phys 2002, 53:847–853. Unique trial measuring long-term quality of life after radiotherapy of patients with stage I NSCLC.

    Article  Google Scholar 

  35. Dupuy DE, Zagoria RJ, Akerley W, et al.: Percutaneous radiofrequency ablation of malignancies in the lung? Am J Roentgenol 2000, 174:57–59.

    CAS  Google Scholar 

  36. Wood BJ, Ramkaransingh JR, Fojo T, et al.: Percutaneous tumor ablation with radiofrequency? Cancer 2002, 94:443–451.

    Article  PubMed  Google Scholar 

  37. Furuse K, Fukuoka M, Kawahara M, et al.: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer? J Clin Oncol 1999, 17:2692–2699. Initial prospective trial demonstrating the superiority of concurrent chemoradiotherapy (over sequential therapy) for patients with locally advanced NSCLC.

    PubMed  CAS  Google Scholar 

  38. Curran WJ Jr, Scott C, Langer C, et al.: Phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer (NSCLC): initial report of Radiation Therapy Oncology Group (RTOG) 9410 [abstract]? Proc Am Soc Clin Oncol 2002, 19:484a.

    Google Scholar 

  39. Arteaga CL, Johnson DH: Tyrosine kinase inhibitors-ZD1839 (Iressa)? Curr Opin Oncol 2001, 13:491–498.

    Article  PubMed  CAS  Google Scholar 

  40. Uematsu MD, Shioda A, Suda A, et al.: Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: a 5-year experience? Int J Radiat Oncol Biol Phys 2001, 51:666–670.

    Article  PubMed  CAS  Google Scholar 

  41. Onimaru R, Shirato H, Shimizul S, et al.: Tumor control and respiratory function after stereotactic irradiation (STI) for primary and metastatic lung cancer [abstract]? Int J Radiat Oncol Biol Phys 2001, 51:345.

    Article  Google Scholar 

  42. Nagata Y, Negoro T, Aoki T, et al.: Clinical outcomes of 3-D conformal hypofractionated single high dose radiotherapy for one or two lung tumors using a stereotactic body frame [abstract]? Int J Radiat Oncol Biol Phys 2001, 51:352–353.

    Article  Google Scholar 

  43. Hara R, Itami J, Kondo T, et al.: Stereotactic single high dose irradiation of lung tumors under respiratory gating? Radiother Oncol 2002, 63:159–163.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Upstate Medical University, 750 E. Adams Street, 13210, Syracuse, NY, USA

    Jeffrey A. Bogart MD

Authors
  1. Jeffrey A. Bogart MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ernest Scalzetti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elisabeth Dexter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bogart, J.A., Scalzetti, E. & Dexter, E. Early stage medically inoperable non-small cell lung cancer. Curr. Treat. Options in Oncol. 4, 81–88 (2003). https://doi.org/10.1007/s11864-003-0034-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-003-0034-7

Keywords

Search

Navigation